Thursday, August 4, 2022

Mobile operator Veon Q2 revenue rises on subscriber growth, pricing strategy

Mobile operator Veon reported a 5.6% rise in second-quarter revenue on Thursday, driven by a rising number of subscribers and an inflationary pricing strategy. https://ift.tt/O1SM8NG

No comments:

Post a Comment

The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain implant; the device contains 1,024 metal electrodes (Ike Swetlitz/Bloomberg)

Ike Swetlitz / Bloomberg : The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain im...